Physician profile
Robert Bruce Bracken
NPI 1386612398
$3,446.67
in general payments reported to CMS, 2019-2025
17 companies · $18.73 in 2025
The $18.73 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $933 · 2020: $453 · 2021: $1,163 · 2022: $621 · 2023: $259 · 2025: $18.73.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $259 · Entertainment: $18.73.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $259.09 |
| Entertainment | $18.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $993.70 | 2019-2021 | |
| Janssen Biotech, INC. | $824.20 | 2019-2022 | |
| Olympus America INC. | $449.07 | 2019-2023 | Itind System, Olympus, Cysto-Nephro Videoscope |
| Janssen Scientific Affairs, LLC | $314.61 | 2019-2022 | |
| Endo Pharmaceuticals INC. | $277.77 | 2019-2022 | |
| C. R. Bard, INC. & Subsidiaries | $165.24 | 2019 | |
| Myovant Sciences INC. | $158.87 | 2021-2022 | |
| Pfizer INC. | $98.64 | 2019 | |
| Rochester Medical Corporation | $35.70 | 2019-2022 | |
| Urogen Pharma, INC. | $29.64 | 2022 | |
| Blue Earth Diagnostics | $24.39 | 2019 | |
| Argentum Medical | $18.73 | 2025 | |
| Merck Sharp & Dohme LLC | $18.50 | 2022 | |
| Amgen INC. | $17.57 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $11.50 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $8.54 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Bracken listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.